Dr. Byung Yang serves as the Chief, Public Health & Product Deployment Strategy at the Bio Investments Group. As such, he is accountable for leading the organization’s product strategy priorities, specifically vaccines and help in optimizing the public health.

Dr. Byung Guk Yang is a renowned figure in the field of public health, particularly known for his exceptional leadership during his tenure as the former head of the Korean Centers for Disease Control and Prevention (KCDC). His career, rooted in a commitment to serving the Korean community, began with a medical degree, followed by further studies in epidemiology and public health. Dr. Yang's leadership within the KCDC marked a transformative period in Korean healthcare, making the country a global model for disease surveillance, response, and prevention.

Dr. Yang's most prominent moment came during the COVID-19 pandemic when his visionary leadership guided Korea through these challenging times. Under his direction, the KCDC implemented groundbreaking initiatives such as mass testing and transparent communication, earning global recognition and showcasing Korea as a leader in public health crisis management. His ability to bridge science and policy ensured that evidence-based approaches played a crucial role in public health decision-making.

In addition to his domestic contributions, Dr. Yang actively participated in international health collaborations, strengthening Korea's position as a trusted partner in global infectious disease control. His humility, dedication, and unwavering commitment to public health earned him the respect of colleagues and citizens alike.